Search Results for: stem cell therapy

Weekly reads: NAM dubs 3 stem cell researchers, kick the 2 buckets, stem cell homing

Sally Temple, stem cell researchers

The National Academy of Medicine elected a cohort of new members including three stem cell researchers. It’s great to see our field and these great scientists get recognition. The new NAM stem cell researchers include Sally Temple, Connie Eaves, and Tippie MacKenzie. Here’s a little bit about each of them. Dr. Temple is a stem cell biologist […]

Weekly reads: NAM dubs 3 stem cell researchers, kick the 2 buckets, stem cell homing Read More »

Weekly reads: upbeat stem cell clinical trials update, CRISPR ups & downs, story of 1st marrow transplant survivor

stem cell clinical trials

It’s always great to read about stem cell clinical trials that are looking encouraging. Stem cell clinical trials Proving a new therapy is safe and effective is so challenging. Remarkably, there are more than 9,300 stem cell clinical trials listed for a “stem cell” search on Clinicaltrials.gov. Of course, not all of these are actual

Weekly reads: upbeat stem cell clinical trials update, CRISPR ups & downs, story of 1st marrow transplant survivor Read More »

Weekly stem cell reads: bat stem cells, brainier organoids, more

bat stem cell

I’m working to send out a big grant on Tuesday so I’m busier than ever but a few stem cell and regenerative medicine stories caught my eye. I can’t write grants 24/7 without a few breaks although sometimes it feels like that’s what I’m doing. Bat stem cell derivation Pluripotent bat stem cells as a

Weekly stem cell reads: bat stem cells, brainier organoids, more Read More »

Labeled diagram of the skin & skin stem cells in research

Labeled diagram of the skin

I’ve been teaching Histology here at UC Davis School of Medicine for more than 12 years and I lecture on skin among other topics so I’ve made more than one labeled diagram of the skin over the years. I’ve included some in this post. First, below you can see a zoomed0out view of fingertip with

Labeled diagram of the skin & skin stem cells in research Read More »

Weekly reads: stem cell activator, sleep & stem cells, clonal hematopoiesis

stem cells macrophages, stem cell activator

When people find out that I’m a stem cell researcher, a common question is whether there’s something they can take that is a stem cell activator. I’ve written before about whether there are stem cell boosts that one can do to try to be healthier. Sleep, stem cell activator and clonality Mostly when I bring

Weekly reads: stem cell activator, sleep & stem cells, clonal hematopoiesis Read More »

Weekly reads: CRISPR, FDA stem cell loss, pioneering AMD study, MS, Verve Therapeutics

FDA stem cell policy flow chart.

The big news of the week was the big FDA stem cell in court by Judge Jesus Bernal here in California, who ruled in favor of a chain of stem cell clinics called Cell Surgical Network. The FDA had been seeking an injunction against the clinics. I believe the ruling was founded in part on

Weekly reads: CRISPR, FDA stem cell loss, pioneering AMD study, MS, Verve Therapeutics Read More »

Fact-checking exosome therapy: costs, risks, & lack of data

model of an exosome, exosome therapy

Exosome therapy is a still-experimental cell therapy approach aimed at treating specific diseases using secretions from cells. It’s novel since most attention on cell therapies has been given to using the actual cells themselves. In addition, this approach is a newer idea than using cells as the drug to treat diseases. Interestingly, the term “cell

Fact-checking exosome therapy: costs, risks, & lack of data Read More »

Weekly stem cell reads: space, plagiarism, HIV, diabetes, more

blood stem cell biology

I took a cross-country road trip earlier this month that was pretty amazing and barely thought about stem cell research for the first time in years. We did run across one stem cell clinic in Florida by accident. I’ll write about that trip soon, but first we have our weekly reads including some very cool

Weekly stem cell reads: space, plagiarism, HIV, diabetes, more Read More »

ViaCyte purchase puts Vertex in driver’s seat on stem cells for diabetes

Doug Melton, Vertex, ViaCyte

When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade. It’s really that promising even though there are

ViaCyte purchase puts Vertex in driver’s seat on stem cells for diabetes Read More »